Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 11020712)

1.

Temporally controlled somatic mutagenesis in smooth muscle.

Kühbandner S, Brummer S, Metzger D, Chambon P, Hofmann F, Feil R.

Genesis. 2000 Sep;28(1):15-22.

PMID:
11020712
2.

Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.

Higashi AY, Ikawa T, Muramatsu M, Economides AN, Niwa A, Okuda T, Murphy AJ, Rojas J, Heike T, Nakahata T, Kawamoto H, Kita T, Yanagita M.

J Immunol. 2009 May 1;182(9):5633-40. doi: 10.4049/jimmunol.0802413.

3.

The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.

Vasioukhin V, Degenstein L, Wise B, Fuchs E.

Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8551-6.

4.

Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.

Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14559-63.

5.

Site- and time-specific gene targeting in the mouse.

Metzger D, Chambon P.

Methods. 2001 May;24(1):71-80.

PMID:
11327805
6.

Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.

Boross P, Breukel C, van Loo PF, van der Kaa J, Claassens JW, Bujard H, Schönig K, Verbeek JS.

Genesis. 2009 Nov;47(11):729-35. doi: 10.1002/dvg.20549.

PMID:
19621440
7.

Local Cre-mediated gene recombination in vascular smooth muscle cells in mice.

Zadelaar SM, Boesten LS, Pires NM, van Nieuwkoop A, Biessen EA, Jukema W, Havekes LM, van Vlijmen BJ, Willems van Dijk K.

Transgenic Res. 2006 Feb;15(1):31-6.

PMID:
16475008
8.

A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.

Undeutsch H, Löf C, Offermanns S, Kero J.

Genesis. 2014 Apr;52(4):333-40. doi: 10.1002/dvg.22740. Epub 2014 Jan 15.

PMID:
24395757
9.
10.

Ligand-activated site-specific recombination in mice.

Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10887-90.

11.

Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.

Qiu HY, Guo C, Cheng XW, Huang Y, Xiong ZQ, Ding YQ.

Genesis. 2008 Jun;46(6):324-8. doi: 10.1002/dvg.20399.

PMID:
18543300
12.

Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.

Yokoi H, Kasahara M, Mukoyama M, Mori K, Kuwahara K, Fujikura J, Arai Y, Saito Y, Ogawa Y, Kuwabara T, Sugawara A, Nakao K.

Nephrol Dial Transplant. 2010 Jul;25(7):2120-4. doi: 10.1093/ndt/gfq029. Epub 2010 Feb 11.

13.

Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.

Hirrlinger PG, Scheller A, Braun C, Hirrlinger J, Kirchhoff F.

Glia. 2006 Jul;54(1):11-20.

PMID:
16575885
14.

Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.

Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD.

Circ Res. 2001 Jul 6;89(1):20-5.

15.

A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action.

Guo C, Yang W, Lobe CG.

Genesis. 2002 Jan;32(1):8-18.

PMID:
11835669
16.

Targeted somatic mutagenesis in mouse epidermis.

Indra AK, Li M, Brocard J, Warot X, Bornert JM, Gérard C, Messaddeq N, Chambon P, Metzger D.

Horm Res. 2000;54(5-6):296-300.

PMID:
11595821
17.

Tamoxifen-inducible Cre-mediated recombination in adipocytes.

Sassmann A, Offermanns S, Wettschureck N.

Genesis. 2010 Oct 1;48(10):618-25. doi: 10.1002/dvg.20665.

PMID:
20715175
18.
19.

Inducible Cre mice.

Feil S, Valtcheva N, Feil R.

Methods Mol Biol. 2009;530:343-63. doi: 10.1007/978-1-59745-471-1_18.

PMID:
19266339
20.

Inducible gene inactivation in neurons of the adult mouse forebrain.

Erdmann G, Schütz G, Berger S.

BMC Neurosci. 2007 Aug 2;8:63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk